Saved in:
Bibliographic Details
Main Authors: Ye, Haicheng, Li, Dan, Zhang, Lei, Wang, Yufei, Wang, Cong, Jin, Meng, Lin, Houwen, Li, Peihai, Sun, Chen, Li, Ning
Format: Artículo científico
Language:en
Published: Marine drugs 2025
Subjects:
Online Access:https://pubmed.ncbi.nlm.nih.gov/40278296/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266211782950912
author Ye, Haicheng
Li, Dan
Zhang, Lei
Wang, Yufei
Wang, Cong
Jin, Meng
Lin, Houwen
Li, Peihai
Sun, Chen
Li, Ning
author_facet Ye, Haicheng
Li, Dan
Zhang, Lei
Wang, Yufei
Wang, Cong
Jin, Meng
Lin, Houwen
Li, Peihai
Sun, Chen
Li, Ning
Ye, Haicheng
Li, Dan
Zhang, Lei
Wang, Yufei
Wang, Cong
Jin, Meng
Lin, Houwen
Li, Peihai
Sun, Chen
Li, Ning
collection PubMed - marine biology
contents Epicoccin A Ameliorates PD-like Symptoms in Zebrafish: Enhancement of PINK1/Parkin-Dependent Mitophagy and Inhibition of Excessive Oxidative Stress. Ye, Haicheng Li, Dan Zhang, Lei Wang, Yufei Wang, Cong Jin, Meng Lin, Houwen Li, Peihai Sun, Chen Li, Ning Animals Zebrafish Oxidative Stress Mitophagy Ubiquitin-Protein Ligases Parkinson Disease Zebrafish Proteins Reactive Oxygen Species Disease Models, Animal Molecular Docking Simulation Neuroprotective Agents Dopaminergic Neurons Protein Kinases Protein Serine-Threonine Kinases PTEN-Induced Putative Kinase Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, yet effective agents for its prevention and therapy remain highly limited. Epicoccin A, a significant secondary metabolite from sp., demonstrates various biological activities; however, its neuroprotective effects have not been elucidated. Here, we investigated the therapeutic potential of epicoccin A for PD by evaluating its impact on neural phenotype, reactive oxygen species (ROS) generation, and locomotor activity in PD-like zebrafish. Transcriptomic analysis and molecular docking were conducted, with key gene expressions further verified using real-time qPCR. As a result, epicoccin A notably mitigated dopaminergic neuron loss, neural vasculature deficiency, nervous system injury, ROS accumulation, locomotor impairments, and abnormal expressions of hallmark genes associated with PD and oxidative stress. Underlying mechanism investigation indicated epicoccin A may alleviate PD-like symptoms by activating PINK1/Parkin-dependent mitophagy, as evidenced by the reversal of aberrant gene expressions related to the pink1/parkin pathway and its upstream mTOR/FoxO pathway following epicoccin A co-treatments. This finding was further confirmed by the robust interactions between epicoccin A and these mitophagy regulators. Our results suggest that epicoccin A relieves PD symptoms by activating pink1/parkin-dependent mitophagy and inhibiting excessive oxidative stress, highlighting its potential as a therapeutic approach for PD.
format Artículo científico
id pubmed_40278296
institution PubMed
language en
publishDate 2025
publisher Marine drugs
record_format pubmed
spellingShingle Epicoccin A Ameliorates PD-like Symptoms in Zebrafish: Enhancement of PINK1/Parkin-Dependent Mitophagy and Inhibition of Excessive Oxidative Stress.
Ye, Haicheng
Li, Dan
Zhang, Lei
Wang, Yufei
Wang, Cong
Jin, Meng
Lin, Houwen
Li, Peihai
Sun, Chen
Li, Ning
Animals
Zebrafish
Oxidative Stress
Mitophagy
Ubiquitin-Protein Ligases
Parkinson Disease
Zebrafish Proteins
Reactive Oxygen Species
Disease Models, Animal
Molecular Docking Simulation
Neuroprotective Agents
Dopaminergic Neurons
Protein Kinases
Protein Serine-Threonine Kinases
PTEN-Induced Putative Kinase
Epicoccin A Ameliorates PD-like Symptoms in Zebrafish: Enhancement of PINK1/Parkin-Dependent Mitophagy and Inhibition of Excessive Oxidative Stress. Ye, Haicheng Li, Dan Zhang, Lei Wang, Yufei Wang, Cong Jin, Meng Lin, Houwen Li, Peihai Sun, Chen Li, Ning Animals Zebrafish Oxidative Stress Mitophagy Ubiquitin-Protein Ligases Parkinson Disease Zebrafish Proteins Reactive Oxygen Species Disease Models, Animal Molecular Docking Simulation Neuroprotective Agents Dopaminergic Neurons Protein Kinases Protein Serine-Threonine Kinases PTEN-Induced Putative Kinase Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, yet effective agents for its prevention and therapy remain highly limited. Epicoccin A, a significant secondary metabolite from sp., demonstrates various biological activities; however, its neuroprotective effects have not been elucidated. Here, we investigated the therapeutic potential of epicoccin A for PD by evaluating its impact on neural phenotype, reactive oxygen species (ROS) generation, and locomotor activity in PD-like zebrafish. Transcriptomic analysis and molecular docking were conducted, with key gene expressions further verified using real-time qPCR. As a result, epicoccin A notably mitigated dopaminergic neuron loss, neural vasculature deficiency, nervous system injury, ROS accumulation, locomotor impairments, and abnormal expressions of hallmark genes associated with PD and oxidative stress. Underlying mechanism investigation indicated epicoccin A may alleviate PD-like symptoms by activating PINK1/Parkin-dependent mitophagy, as evidenced by the reversal of aberrant gene expressions related to the pink1/parkin pathway and its upstream mTOR/FoxO pathway following epicoccin A co-treatments. This finding was further confirmed by the robust interactions between epicoccin A and these mitophagy regulators. Our results suggest that epicoccin A relieves PD symptoms by activating pink1/parkin-dependent mitophagy and inhibiting excessive oxidative stress, highlighting its potential as a therapeutic approach for PD.
title Epicoccin A Ameliorates PD-like Symptoms in Zebrafish: Enhancement of PINK1/Parkin-Dependent Mitophagy and Inhibition of Excessive Oxidative Stress.
topic Animals
Zebrafish
Oxidative Stress
Mitophagy
Ubiquitin-Protein Ligases
Parkinson Disease
Zebrafish Proteins
Reactive Oxygen Species
Disease Models, Animal
Molecular Docking Simulation
Neuroprotective Agents
Dopaminergic Neurons
Protein Kinases
Protein Serine-Threonine Kinases
PTEN-Induced Putative Kinase
url https://pubmed.ncbi.nlm.nih.gov/40278296/